Utama › Penyakit Hati Steatotik
Kajian klinikal Penyakit Hati Steatotik sedang mengambil peserta di AS
65 kajian untuk Penyakit Hati Steatotik sedang mengambil peserta di lokasi seluruh Amerika Syarikat.
Bandar dengan paling banyak kajian
- San Antonio, TX17 kajian
- New York City, NY16 kajian
- Miami, FL16 kajian
- San Diego, CA14 kajian
- Austin, TX13 kajian
- Houston, TX13 kajian
- Richmond, VA12 kajian
- Tucson, AZ10 kajian
- Chandler, AZ10 kajian
- Orlando, FL9 kajian
- Hialeah, FL9 kajian
- St. Louis, MO9 kajian
- Dallas, TX9 kajian
- Durham, NC8 kajian
- Dayton, OH8 kajian
- Little Rock, AR8 kajian
- Los Angeles, CA8 kajian
- New Orleans, LA8 kajian
- Pasadena, CA8 kajian
- Ocala, FL8 kajian
- Rochester, MN8 kajian
- Akron, OH7 kajian
- Seattle, WA7 kajian
- Washington, DC7 kajian
- Parma, OH7 kajian
- Lancaster, CA7 kajian
- Brownsville, TX7 kajian
- Topeka, KS7 kajian
- Las Vegas, NV7 kajian
- Round Rock, TX7 kajian
- Chicago, IL6 kajian
- Sugar Land, TX6 kajian
- Cape Coral, FL6 kajian
- Sarasota, FL6 kajian
- Sandy Springs, GA6 kajian
- Peoria, AZ6 kajian
- Indianapolis, IN6 kajian
- Fort Worth, TX6 kajian
- Fayetteville, NC6 kajian
- Arlington, TX6 kajian
Mengikut negeri
- Alabama4 kajian
- Arizona14 kajian
- Arkansas8 kajian
- California22 kajian
- Colorado6 kajian
- Connecticut5 kajian
- Florida20 kajian
- Georgia8 kajian
- Illinois6 kajian
- Indiana9 kajian
- Iowa4 kajian
- Kansas7 kajian
- Kentucky4 kajian
- Louisiana11 kajian
- Maryland8 kajian
- Massachusetts9 kajian
- Michigan8 kajian
- Minnesota9 kajian
- Mississippi5 kajian
- Missouri14 kajian
- Nevada7 kajian
- New Jersey6 kajian
- New Mexico3 kajian
- New York17 kajian
- North Carolina13 kajian
- Ohio15 kajian
- Pennsylvania5 kajian
- Rhode Island3 kajian
- South Carolina5 kajian
- Tennessee7 kajian
- Texas20 kajian
- Utah5 kajian
- Virginia14 kajian
- Washington7 kajian
Kajian yang dikemas kini baru-baru ini
Teks kajian rasmi (Bahasa Inggeris)
A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
Mengambil pesertaFasa 3
Umur 18 hingga 75 · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07704892A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
Mengambil pesertaFasa 3
Umur 18 hingga 75 · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07701993A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD
Mengambil pesertaFasa 2
Umur 18 hingga 75 · Semua jantina · Dikemas kini 29 Sep 2026 · NCT07527910Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
Mengambil pesertaFasa 2
Umur 18 hingga 75 · Semua jantina · Dikemas kini 28 Sep 2026 · NCT05832229Early Tracking of Childhood Health Determinants (ETCHED) Study
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
1 Day – 99 Years · Semua jantina · Dikemas kini 28 Sep 2026 · NCT03481829A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
Mengambil pesertaFasa 2
Umur 18 hingga 75 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT05519475A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07165028Impact of Soymilk on Liver Disease Severity of Children With Non-alcoholic Fatty Liver Disease (NAFLD)
Mengambil pesertaFasa 2
Umur 5 hingga 16 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT06133101A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Mengambil pesertaFasa 3
Umur 18 hingga 80 · Semua jantina · Dikemas kini 21 Sep 2026 · NCT06528314A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
Mengambil pesertaFasa 3
Umur 18 hingga 75 · Semua jantina · Dikemas kini 17 Sep 2026 · NCT07221188Fully Automated High-Throughput Quantitative MRI of the Liver
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 7 ke atas · Semua jantina · Dikemas kini 16 Sep 2026 · NCT05294471A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
Mengambil pesertaFasa 2
Umur 18 hingga 75 · Semua jantina · Dikemas kini 9 Sep 2026 · NCT07288138A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Mengambil pesertaFasa 3
Umur 18 hingga 80 · Semua jantina · Dikemas kini 3 Sep 2026 · NCT06318169A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Mengambil pesertaFasa 3
Umur 18 hingga 75 · Semua jantina · Dikemas kini 3 Sep 2026 · NCT06419374Human Models of Selective Insulin Resistance: Alpelisib, Part I
Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan
Umur 18 hingga 70 · Semua jantina · Dikemas kini 24 Ogo 2026 · NCT06354088Quantifying Hepatic Mitochondrial Fluxes in Humans
Mengambil pesertaFasa 4
Umur 18 hingga 80 · Semua jantina · Dikemas kini 17 Ogo 2026 · NCT05305287InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Semua umur · Semua jantina · Dikemas kini 17 Ogo 2026 · NCT05463796Acute Exercise and Endogenous Glucose Production in Type 2 Diabetes: Implications for Glycemic Control and Treatment of Hepatic Steatosis
Mengambil pesertaSukarelawan sihat dialu-alukan
Umur 25 hingga 55 · Semua jantina · Dikemas kini 12 Ogo 2026 · NCT06993454Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
Mengambil pesertaFasa 2Sukarelawan sihat dialu-alukan
Umur 18 hingga 100 · Semua jantina · Dikemas kini 10 Ogo 2026 · NCT03884075Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity
Mengambil pesertaSukarelawan sihat dialu-alukan
Umur 18 hingga 70 · Semua jantina · Dikemas kini 6 Ogo 2026 · NCT06335771Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity (ATM)
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 18 hingga 70 · Semua jantina · Dikemas kini 6 Ogo 2026 · NCT06571474Effects of Peanut Consumption on Adults With Metabolic Associated Fatty Liver Disease
Mengambil peserta
Umur 30 hingga 70 · Semua jantina · Dikemas kini 6 Ogo 2026 · NCT07646197A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
Mengambil pesertaFasa 2
Umur 18 hingga 70 · Semua jantina · Dikemas kini 3 Ogo 2026 · NCT06613698Fibrosis Lessens After Metabolic Surgery
Mengambil pesertaFasa 4Sukarelawan sihat dialu-alukan
Umur 18 hingga 75 · Semua jantina · Dikemas kini 31 Jul 2026 · NCT06374875Pathogenesis of Pediatric Nonalcoholic Fatty Liver Disease (NAFLD)
Mengambil pesertaKajian pemerhatian
Umur 12 hingga 18 · Semua jantina · Dikemas kini 30 Jul 2026 · NCT04634643Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.